Greenpark Compounding Pharmacy produced and distributed compounded products from Prescription Labs Inc. nationwide. These products are intended to be sterile and could be life-threatening if used when not sterile. FDA discovered in July/August that the conditions of Greenpark Compounding Pharmacy’s facility could be causing contamination to the compounded drugs they were manufacturing. On August 18…
Read more
Innovation Begins with a Problem
Dr. Thomas Ingallinera from Pharmaceuticals International Inc. has a motto, “challenges frame opportunities”. This motto supports many situations within the pharmaceutical industries as well as others. When companies face issues, that is when they decide that they need to make changes and updates. This system is not always the best, because when a problem occurs,…
Read more
Robotics, Isolators & Restricted Access Barrier Systems
Aseptic Process is the process for manufacturing sterile products where microbiological contaminants could not enter the production area or surface of the product. It is challenging for pharmaceutical manufacturers to ensure that the product they are handling will have absolutely no contaminants—especially if involving parenteral drugs. To isolate human contamination, it is beneficial to use…
Read more
Innoveix Pharmaceuticals, Inc. Recall
Innoveix Pharmaceuticals, Inc. recently voluntarily recalled lots of sterile compounded drug products. Semorelin/ Ipamorelin 3mg and injectable AOD-9604 3mg were the products that were recalled from specific Lots. These products were not sterile—when intended to be sterile. Having non-sterile products could lead to life-threatening infections. These products were distributed nationwide to customers and medical facilities.…
Read more